Eylea HD® (aflibercept)
for Macular Degeneration

Eylea HD (aflibercept) is a long-acting eye injection used to treat neovascular (wet) age-related macular degeneration (nAMD), diabetic macular edema (DME), and diabetic retinopathy (DR). It is a VEGF inhibitor that blocks VEGF-A and PlGF, proteins that promote abnormal blood vessel growth. By targeting these factors, Eylea HD helps reduce leakage and swelling in the retina, preserving vision and managing disease progression.

Heart
Medication Guide Icon Medication Guide
TV Commercial Icon TV Commercial
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Macular Degeneration